Japan Diagnostic Imaging Market-Market Dynamics
Paying for diagnostic imaging procedures is easier in Japan than it is in other Asian countries. Not only do the Japanese have high average annual incomes but they also have a government that provides some form of health insurance to all individuals. Japan's Ministry of Health and Welfare has established the MRI reimbursement rate at USD 200 per scan, one-fifth of the US average.
Factors contributing to the growth of the diagnostic imaging market in Japan include increased incidence of chronic diseases, high levels of healthcare expenditure and a massive elderly population. Nearly one in three Japanese citizens are older than 60, and many of them suffer from chronic conditions requiring diagnostic imaging. Until recently, many elderly Asians with chronic conditions (like cancers, kidney disease, heart disease, brain and joint disorders) had gone undiagnosed for decades. But as the per capita GDP increased, more and more of them could afford to spend on diagnostic methods and treatment. Growth trends for the future also include higher demand for mammography equipment, nuclear imaging equipment, and low dosage imaging.
The side effects of diagnostic imaging procedures and saturation in the developed regions are the major challenges faced by the diagnostic imaging equipment. Cost rarely gets in the way of medical imaging procedures in Japan. There is no healthcare cost crisis in Japan.
The market is segmented based on type (X-ray, MRI, nuclear medicine, ultrasound, tomography, tactile imaging, photoacoustic imaging, thermography, elastography, echocardiography, and functional near infrared spectroscopy).
Medical imaging technology is a rapidly changing field, and healthcare organizations have multiple options for new acquisitions. Many players in this market are trying to expand their product portfolio in order to top the global market. A few companies have adopted product innovation and new product launches as their key business strategy to ensure their dominance in this market.
Market analysis for the Japan diagnostic imaging market, with region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share.
Identification and analysis of the macro and micro factors that affect the Japan diagnostic imaging market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
2. Market Definition
3. Market Drivers
4. Market Restraints
5. Diagnostic Imaging
7. Segmentation by Type
7.1.2 Projectional Radiographs
7.3 Nuclear Medicine
7.6 Tactile Imaging
7.7 Photoacoustic Imaging
7.11 Functional near infrared spectroscopy
8. Trends and implementation issues in Asia-Pacific countries
9. Factors affecting appropriate usage of diagnostic techniques
10. Factors influencing investment in diagnostic imaging market
11. Asia-Pacific Diagnostic Imaging Market 2016- 2021 (Growth, Forecasts, CAGR)
11.1 China 2016-2021 (Growth, Forecasts, CAGR)
11.2 India 2016-2021 (Growth, Forecasts, CAGR)
11.3 Japan 2016- 2021 (Growth, Forecasts, CAGR)
11.4 Australia 2016- 2021 (Growth, Forecasts, CAGR)
11.5 Rest of Asia 2016- 2021 (Growth, Forecasts, CAGR)
12. Competitive Landscape
13. Key players in the market
13.1 Fujifilm Holding
13.2 Shimadzu Corporation
13.3 Toshiba Healthcare systems
13.4 Hitachi Healthcare systems
13.5 Samsung Medison